1 / 6

Schizophrenia Drugs Market - to Enter a New Phase of Expansion

Schizophrenia Drugs Market by Drug Class (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs); Route of Administration( Oral and Injectable), Regional Analysis & Forecast

pharmahealth
Download Presentation

Schizophrenia Drugs Market - to Enter a New Phase of Expansion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Schizophrenia Drugs Market Drug Class: First Generation Drugs, Second Generation Drugs, and Third Generation Drugs; Route of Administration: Oral and Injectable Forecast 2019 - 2027 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Schizophrenia Drugs Market Chapter 4 Market Overview Chapter 5 Key Insights Chapter 6 Global Schizophrenia Drugs Market Analysis and Forecast, by Drug Class Chapter 7 Global Schizophrenia Drugs Market Analysis and Forecast, by Route of Administration Chapter 8 Global Schizophrenia Drugs Market Analysis and Forecast, by Region Chapter 9 North America Schizophrenia Drugs Market Analysis and Forecast Chapter 10 Europe Schizophrenia Drugs Market Analysis and Forecast Chapter 11 Asia Pacific Schizophrenia Drugs Market Analysis and Forecast Chapter 12 Latin America Schizophrenia Drugs Market Analysis and Forecast Chapter 13 Middle East & Africa Schizophrenia Drugs Market Analysis and Forecast Chapter 14 Competition Landscape

  3. ©2019 Transparency Market Research, All Rights Reserved Schizophrenia Drugs Market: Snapshot Rise in the prevalence of schizophrenia, approvals for additional indications, and launch of new schizophrenia drugs are driving the schizophrenia drugs market. • • Based on drug class, the global schizophrenia drugs market has been categorized into first generation drugs, second generation drugs, and third generation drugs. • Increase in the number of launches of new schizophrenia drugs in various countries is fueling the global schizophrenia drugs market. ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • The schizophrenia drugs market was valued at ~US$ 11.2 Bn in 2018, and is projected to reach ~US$ 15.5 Bn by 2027, expanding at a CAGR of ~4% from 2019 to 2027. Mergers & Acquisitions to Strengthen Market Position In February 2015, Pfizer, Inc. and Hospira, Inc. (a leading player in infusion technologies and injectable drugs) signed a merger agreement. Under the agreement, Pfizer would acquire Hospira for a total transaction value of ~US$ 17 Bn. This complementary merger would help in expanding the company’s portfolio of sterile injectable pharmaceuticals and biosimilars. ©2019 Transparency Market Research, All Rights Reserved Request Sample

  6. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related